IKT
Inhibikase Therapeutics, Inc.
There isn't enough reported data to score IKT yet.
LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
IKT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
IKT's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
IKT PE Valuation
IKT has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
IKT Forward outlook
There aren't enough analyst estimates for IKT to show an outlook.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
IKT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$2.68 | +$1.33 |
| Q2 2024 | -$2.89 | +$1.34 |
| Q1 2024 | -$3.34 | +$0.86 |
| Q4 2023 | -$3.57 | +$0.75 |
| Q3 2023 | -$4.01 | +$0.13 |
| Q2 2023 | -$4.23 | -$0.09 |
| Q1 2023 | -$4.20 | +$0.18 |
| Q4 2022 | -$4.32 | +$0.54 |
LLY has the stronger earnings trend. Trailing diluted EPS is down 115% for IKT versus LLY up 51%.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY's earnings per share have climbed steadily: $30.81 over the past year, up 51% from the year before, and higher year over year for 11 quarters in a row.
IKT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $1 | -100% |
| Q3 2023 | $79.6K | +991% |
| Q2 2023 | $116.4K | +1677% |
| Q1 2023 | $64.5K | +40% |
| Q4 2022 | $63.6K | +3170% |
| Q3 2022 | $7.3K | -98% |
| Q2 2022 | $6.6K | -100% |
| Q1 2022 | $46K | -97% |
IKT's revenue is shrinking: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2023 | -440356600% | -440349780 points |
| Q3 2023 | -5993% | +55906 points |
| Q2 2023 | -5328% | +65489 points |
| Q1 2023 | -7308% | +2774 points |
| Q4 2022 | -6820% | +252515 points |
| Q3 2022 | -61900% | -60538 points |
| Q2 2022 | -70817% | -70624 points |
| Q1 2022 | -10081% | -9895 points |
IKT's operating margin was −440356600% last quarter, down 440349780 points from the same quarter a year ago, near the bottom of its range since 2019.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY's revenue has grown year over year for 14 quarters in a row: $24.4B last quarter, up 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY's operating margin was 34% last quarter, down 6.6 points from the same quarter a year ago.
IKT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$17.4M | -$6.8M |
| Q2 2026 | -$12.4M | -$6.9M |
| Q1 2026 | -$12.1M | -$7.9M |
| Q4 2025 | -$7.5M | -$2.2M |
| Q3 2025 | -$10.6M | -$5.7M |
| Q1 2025 | -$4.1M | -$249.9K |
| Q4 2024 | -$5.3M | -$1.9M |
| Q3 2024 | -$4.9M | -$776K |
IKT has burned cash in almost every quarter: −$49M over the past year, against −$26M the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over IKT on cash generation, producing positive trailing cash flow while its opponent burns cash.
IKT Net Leverage
IKT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
IKT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.4 | Neutral |
| Stochastic | 6.5 | Oversold |
IKT's weekly RSI is 35 (neutral) and its Stochastic is 6 (oversold).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
IKT PE vs Healthcare Sector
IKT has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
IKT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.73 | 12% below |
| 20 week MA | $2.07 | 26% below |
| 50 week MA | $1.89 | 19% below |
| 100 week MA | $1.95 | 22% below |
| 200 week MA | $2.13 | 28% below |
IKT is in a downtrend: it's below all five of its weekly moving averages, and 28% below its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over IKT on trend strength, trading above more of its moving averages.
IKT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $58.8 | $58.8 | 0% |
| 2021 | $58.8 | $9.42 | -84% |
| 2022 | $9.42 | $2.97 | -68% |
| 2023 | $2.97 | $1.27 | -57% |
| 2024 | $1.27 | $3.05 | +140% |
| 2025 | $3.05 | $2.00 | -34% |
| 2026 YTD | $2.00 | $1.53 | -24% |
IKT's yearly returns have swung widely, from +140% in 2024 to −84% in 2021. It's down 24% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over IKT on returns for 2026, with the stronger performance.